Replimune

-$1.06 (-2.86%) Today

$0.00 (0.00%) As of 9:15 PM UTC after-hours

Why Robinhood?

You can buy or sell Replimune and other stocks, options, and ETFs commission-free!

About REPL

Replimune Group, Inc. Common Stock, also called Replimune, is a clinical-stage biotechnology company, which engages in the development of oncolytic immunotherapy product candidates through immulytic platform.

CEO

Philip Astley-Sparke

Employees

122

Headquarters

Woburn, Massachusetts

Founded

2015

REPL Key Statistics

Market Cap

1.77B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

434.98K

High Today

$37.77

Low Today

$35.44

Open Price

$36.47

Volume

172.72K

52 Week High

$54.85

52 Week Low

$17.50

Analyst Ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

REPL Earnings

-$0.46

-$0.31

-$0.15

$0.00

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected Jun 3, Pre-Market